Know the Facts about Coronavirus Disease 2019 (COVID-19)

Condition | Cancer

Alliance A021502

  • IRB Number: Alliance A021502
  • Contact Name: Rachel O’Loughlin, RN BSN
  • Status: Enrolling
  • Phone: (585) 747-4555
  • Lead Researcher: Peter Bushunow, MD


Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair